Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Surgilube is a sterile, water-soluble, and non-staining surgical lubricant used primarily to facilitate the insertion of medical instruments and devices into body orifices during surgical and diagnostic procedures. Developed originally by E. Fougera & Co. and currently owned by HR Pharmaceuticals, it is a carbomer-based hydrogel that provides a smooth, viscous interface, significantly reducing friction and protecting mucous membranes from trauma. The formulation is designed to be non-irritating, latex-free, and adheres well to both metal and synthetic surfaces. It is widely utilized in clinical settings for procedures such as catheterization, endoscopy, pelvic examinations, and proctology. Surgilube is available in various sterile formats, including tubes and single-use packets, and is offered in both standard and bacteriostatic versions (the latter often containing chlorhexidine gluconate).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Surgilube.